Venus Cochlear News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Venus cochlear. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Venus Cochlear Today - Breaking & Trending Today
BONEBRIDGE (MED-EL), Ponto 4 (Oticon Medical), Esteem® osseointegrated active middle ear implant (AMEI) (Envoy Medical), Venus Cochlear implant system (Nurotron Biotechnology) are some of the Age-related Hearing Loss devices available in the market. Most of these available devices are FDA-approved and are CE marked. Certain emerging devices/therapeutics in the Age-related Hearing Loss market comprise the Acclaim® Cochlear Implant FX-322 (Frequency Therapeutics), among others. On June 29, 2020, Acclaim® cochlear implant was granted the Breakthrough Device Designation from the FDA. In March 2020, Advanced Bionics announced a voluntary recall of the initial version of its HiRes Ultra and Ultra 3D cochlear implant devices due to a decrease in performance experienced by some recipients. The company developed several advances, comprising a new version of the device, to address the issue, and it received regulatory approval in the US and ....
Share: Hereditary Deafness Market Expected to Rise by a CAGR of 4.09% by 2026, Claims DelveInsight The Hereditary Deafness market is anticipated to surge due to an increasing prevalence of hearing loss patients and technological advancements. DelveInsight s Hereditary Deafness Market and Competitive Insight Report provides the current and forecast market and comprises Hereditary Deafness market trends and key competitors. DelveInsight estimated the market to grow at a high CAGR over the study period of 2018 – 2026. Key Highlights of : Deafness can be transferred from parents to the child and can develop over time during childhood or adulthood. It can be autosomal recessive or dominant, X-linked, or mitochondrial-related. Almost ....